Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study

被引:11
作者
Hasegawa, Minoru [1 ]
Asano, Yoshihide [2 ]
Endo, Hirahito [3 ]
Fujimoto, Manabu [1 ]
Goto, Daisuke [4 ]
Ihn, Hironobu [5 ]
Inoue, Katsumi [6 ]
Ishikawa, Osamu [7 ]
Kawaguchi, Yasushi [8 ]
Kuwana, Masataka [9 ]
Muro, Yoshinao [10 ]
Ogawa, Fumihide [11 ]
Sasaki, Tetsuo [12 ]
Takahashi, Hiroki [13 ]
Tanaka, Sumiaki [14 ]
Takehara, Kazuhiko [1 ]
Sato, Shinichi [2 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
[2] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan
[3] Toho Univ, Dept Internal Med Omori, Sch Med, Tokyo, Japan
[4] Univ Tsukuba, Dept Rheumatol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan
[5] Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Rehabil Sci, Kanazawa, Ishikawa, Japan
[7] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 371, Japan
[8] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
[9] Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo, Japan
[10] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan
[11] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 852, Japan
[12] Int Univ Hlth & Welf Atami, Dept Dermatol, Atami, Japan
[13] Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan
[14] Kitasato Univ, Dept Rheumatol & Infect Dis, Sch Med, Sagamihara, Kanagawa 228, Japan
关键词
systemic sclerosis; scleroderma; prognostic factor; skin sclerosis; interstitial lung diseases; treatment; EULAR SCLERODERMA TRIALS; RACIAL-DIFFERENCES; THICKNESS SCORE; DISEASE; INVOLVEMENT;
D O I
10.1093/rheumatology/ker333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To clarify the clinical course of SSc in Japanese patients with early-onset disease. It is well known that ethnic variations exist in the clinical features and severity of SSc. However, neither the clinical course nor prognostic factors have been thoroughly investigated in the Japanese population. Methods. Ninety-three Japanese patients of early-onset SSc (disease duration: <3 years) with diffuse skin sclerosis and/or interstitial lung disease were registered in a multi-centre observational study. All patients had a physical examination with laboratory tests at their first visit and at each of the three subsequent years. Factors that could predict the severity of skin sclerosis and lung involvement were examined statistically by multiple regression analysis. Results. Two patients died from SSc-related myocardial involvement and four patients died from other complications during the 3-year study. Among various clinical data assessed, the initial modified Rodnan total skin thickness score (MRSS) and maximal oral aperture were associated positively and negatively with MRSS at Year 3, respectively. Additionally, initial ESR tended to be associated with final MRSS. Pulmonary vital capacity (VC) in the third year was significantly associated with initial %VC. Furthermore, patients with anti-topo I antibody tended to show reduced %VC at Year 3. Conclusions. Several possible prognostic factors for skin sclerosis and lung function were detected in Japanese patients with early SSc. Further longitudinal studies of larger populations will be needed to confirm these findings.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 21 条
[1]   Course of the Modified Rodnan Skin Thickness Score in Systemic Sclerosis Clinical Trials Analysis of Three Large Multicenter, Double-Blind, Randomized Controlled Trials [J].
Amjadi, Sogol ;
Maranian, Paul ;
Furst, Daniel E. ;
Clements, Philip J. ;
Wong, Weng Kee ;
Postlethwaite, Arnold E. ;
Khanna, Puja P. ;
Khanna, Dinesh .
ARTHRITIS AND RHEUMATISM, 2009, 60 (08) :2490-2498
[2]  
CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
[3]  
Committee SFSCOTARADATC, 1982, ARTHRITIS RHEUM, V23, P581, DOI DOI 10.1002/ART.1780230510
[4]   The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis [J].
Hamaguchi, Y. ;
Hasegawa, M. ;
Fujimoto, M. ;
Matsushita, T. ;
Komura, K. ;
Kaji, K. ;
Kondo, M. ;
Nishijima, C. ;
Hayakawa, I. ;
Ogawa, F. ;
Kuwana, M. ;
Takehara, K. ;
Sato, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (03) :487-495
[5]   Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis [J].
Hasegawa, Minoru ;
Fujimoto, Manabu ;
Matsushita, Takashi ;
Hamaguchi, Yasuhito ;
Takehara, Kazuhiko ;
Sato, Shinichi .
CLINICAL RHEUMATOLOGY, 2011, 30 (02) :231-237
[6]  
Kuwana M, 2003, J RHEUMATOL, V30, P1253
[7]   RACIAL-DIFFERENCES IN THE DISTRIBUTION OF SYSTEMIC SCLEROSIS-RELATED SERUM ANTINUCLEAR ANTIBODIES [J].
KUWANA, M ;
OKANO, Y ;
KABURAKI, J ;
TOJO, T ;
MEDSGER, TA .
ARTHRITIS AND RHEUMATISM, 1994, 37 (06) :902-906
[8]   Racial differences in scleroderma among women in Michigan [J].
Laing, TJ ;
Gillespie, BW ;
Toth, MB ;
Mayes, MD ;
Gallavan, RH ;
Burns, CJ ;
Johanns, JR ;
Cooper, BC ;
Keroack, BJ ;
Wasko, MCM ;
Lacey, JV ;
Schottenfeld, D .
ARTHRITIS AND RHEUMATISM, 1997, 40 (04) :734-742
[9]  
LEROY EC, 1988, J RHEUMATOL, V15, P202
[10]  
Medsger T.A., 2004, Systemic Sclerosis, V2nd, P17